1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Harris, R. Hillerich, B. Ahmed, M. Bonanno, J.B. Chamala, S. Evans, B. Lafleur, J. Hammonds, J. Washington, E. Stead, M. Love, J. Attonito, J. Patel, H. Seidel, R.D. Chook, Y.M. Rout, M.P. Girvin, M.E. Almo, S.C. New York Structural Genomics Research Consortium (NYSGRC) Nucleocytoplasmic Transport: a Target for Cellular Control (NPCXstals) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution structure of the RRM domain of the hypothetical protein CAGL0M09691g from Candida glabrata 10.2210/pdb2m4m/pdb pdb_00002m4m 14227.867 hypothetical protein UNP residues 171-283 1 man polymer no no MSLGSESETGNAVVVFGYREAITKQILAYFAQFGEILEDLESELGDTETMRTPGYFFQQAPNRRRISREHGRTWTKLTYA NHSSYLRALREHGTIYCGAAIGCVPYKHELISELSREGHHHHHH MSLGSESETGNAVVVFGYREAITKQILAYFAQFGEILEDLESELGDTETMRTPGYFFQQAPNRRRISREHGRTWTKLTYA NHSSYLRALREHGTIYCGAAIGCVPYKHELISELSREGHHHHHH A NYSGRC-019428 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Yeast CBS 138 sample CAGL0M09691g 284593 Candida glabrata 469008 Escherichia coli BL21(DE3) modified pET26 pET New York Structural Genomics Research Consortium NYSGRC PSI:Biology Nucleocytoplasmic Transport: a Target for Cellular Control NPCXstals PSI:Biology database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer struct_ref_seq_dif repository Initial release Data collection Database references Other 1 0 2013-02-27 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details Y BMRB Y RCSB 2013-02-07 REL REL REL REL 1564 542 308 261 424 12 48 48 All 3D experiments were acquired with 30% non-uniform sampling using the MDDNMR approach 20 structures for lowest energy 100 20 15N HSQC 15N NOESY-HSQC 13C HSQC aromatic 13C HSQC 13C NOESY-HSQC 13C aromatic NOESY-HSQC HNCO HNCACO HNCA HNCOCA HNCACB CBCACONH 1.0 mM [U-100% 13C; U-100% 15N] 10 mM 100 mM 0.5 mM 0.5 mM 1.0 mM [U-100% 13C; U-100% 15N] 10 mM 100 mM 0.5 mM 0.5 mM 110 4.5 1 atm 298 K Refinement in a box of water simulating annealing 1 lowest energy 1.0 mM [U-100% 13C; U-100% 15N] RRM domain of the hypothetical protein, 10 mM sodium acetate, 100 mM sodium chloride, 0.5 mM DTT, 0.5 mM EDTA, 90% H2O, 10% D2O 90% H2O/10% D2O 1.0 mM [U-100% 13C; U-100% 15N] RRM domain of the hypothetical protein, 10 mM sodium acetate, 100 mM sodium chloride, 0.5 mM DTT, 0.5 mM EDTA, 100% D2O 100% D2O Brunger A. T. et.al. refinement CNS 1.21 Varian collection VnmrJ 2.2D Bruker Biospin collection TopSpin 2.1 (MDDNMR) Orekhov, Jaravine, Kazimierczuk collection MddNMR 2.2 (MDDNMR) Orekhov, Jaravine, Kazimierczuk processing MddNMR 2.2 CCPN data analysis CCPN_Analysis 2.2 Linge, O'Donoghue and Nilges data analysis ARIA 2.3 Schwieters, Kuszewski, Tjandra and Clore structure solution X-PLOR NIH 2.32 refinement X-PLOR NIH 600 Varian INOVA Varian Inova 800 Bruker AVANCE Bruker Avance MET 1 n 1 MET 1 A SER 2 n 2 SER 2 A LEU 3 n 3 LEU 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A GLU 6 n 6 GLU 6 A SER 7 n 7 SER 7 A GLU 8 n 8 GLU 8 A THR 9 n 9 THR 9 A GLY 10 n 10 GLY 10 A ASN 11 n 11 ASN 11 A ALA 12 n 12 ALA 12 A VAL 13 n 13 VAL 13 A VAL 14 n 14 VAL 14 A VAL 15 n 15 VAL 15 A PHE 16 n 16 PHE 16 A GLY 17 n 17 GLY 17 A TYR 18 n 18 TYR 18 A ARG 19 n 19 ARG 19 A GLU 20 n 20 GLU 20 A ALA 21 n 21 ALA 21 A ILE 22 n 22 ILE 22 A THR 23 n 23 THR 23 A LYS 24 n 24 LYS 24 A GLN 25 n 25 GLN 25 A ILE 26 n 26 ILE 26 A LEU 27 n 27 LEU 27 A ALA 28 n 28 ALA 28 A TYR 29 n 29 TYR 29 A PHE 30 n 30 PHE 30 A ALA 31 n 31 ALA 31 A GLN 32 n 32 GLN 32 A PHE 33 n 33 PHE 33 A GLY 34 n 34 GLY 34 A GLU 35 n 35 GLU 35 A ILE 36 n 36 ILE 36 A LEU 37 n 37 LEU 37 A GLU 38 n 38 GLU 38 A ASP 39 n 39 ASP 39 A LEU 40 n 40 LEU 40 A GLU 41 n 41 GLU 41 A SER 42 n 42 SER 42 A GLU 43 n 43 GLU 43 A LEU 44 n 44 LEU 44 A GLY 45 n 45 GLY 45 A ASP 46 n 46 ASP 46 A THR 47 n 47 THR 47 A GLU 48 n 48 GLU 48 A THR 49 n 49 THR 49 A MET 50 n 50 MET 50 A ARG 51 n 51 ARG 51 A THR 52 n 52 THR 52 A PRO 53 n 53 PRO 53 A GLY 54 n 54 GLY 54 A TYR 55 n 55 TYR 55 A PHE 56 n 56 PHE 56 A PHE 57 n 57 PHE 57 A GLN 58 n 58 GLN 58 A GLN 59 n 59 GLN 59 A ALA 60 n 60 ALA 60 A PRO 61 n 61 PRO 61 A ASN 62 n 62 ASN 62 A ARG 63 n 63 ARG 63 A ARG 64 n 64 ARG 64 A ARG 65 n 65 ARG 65 A ILE 66 n 66 ILE 66 A SER 67 n 67 SER 67 A ARG 68 n 68 ARG 68 A GLU 69 n 69 GLU 69 A HIS 70 n 70 HIS 70 A GLY 71 n 71 GLY 71 A ARG 72 n 72 ARG 72 A THR 73 n 73 THR 73 A TRP 74 n 74 TRP 74 A THR 75 n 75 THR 75 A LYS 76 n 76 LYS 76 A LEU 77 n 77 LEU 77 A THR 78 n 78 THR 78 A TYR 79 n 79 TYR 79 A ALA 80 n 80 ALA 80 A ASN 81 n 81 ASN 81 A HIS 82 n 82 HIS 82 A SER 83 n 83 SER 83 A SER 84 n 84 SER 84 A TYR 85 n 85 TYR 85 A LEU 86 n 86 LEU 86 A ARG 87 n 87 ARG 87 A ALA 88 n 88 ALA 88 A LEU 89 n 89 LEU 89 A ARG 90 n 90 ARG 90 A GLU 91 n 91 GLU 91 A HIS 92 n 92 HIS 92 A GLY 93 n 93 GLY 93 A THR 94 n 94 THR 94 A ILE 95 n 95 ILE 95 A TYR 96 n 96 TYR 96 A CYS 97 n 97 CYS 97 A GLY 98 n 98 GLY 98 A ALA 99 n 99 ALA 99 A ALA 100 n 100 ALA 100 A ILE 101 n 101 ILE 101 A GLY 102 n 102 GLY 102 A CYS 103 n 103 CYS 103 A VAL 104 n 104 VAL 104 A PRO 105 n 105 PRO 105 A TYR 106 n 106 TYR 106 A LYS 107 n 107 LYS 107 A HIS 108 n 108 HIS 108 A GLU 109 n 109 GLU 109 A LEU 110 n 110 LEU 110 A ILE 111 n 111 ILE 111 A SER 112 n 112 SER 112 A GLU 113 n 113 GLU 113 A LEU 114 n 114 LEU 114 A SER 115 n 115 SER 115 A ARG 116 n 116 ARG 116 A GLU 117 n 117 GLU 117 A GLY 118 n 118 GLY 118 A HIS 119 n 119 HIS 119 A HIS 120 n 120 HIS 120 A HIS 121 n 121 HIS 121 A HIS 122 n 122 HIS 122 A HIS 123 n 123 HIS 123 A HIS 124 n 124 HIS 124 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O THR 75 A O THR 75 A N VAL 15 A N VAL 15 A N VAL 14 A N VAL 14 A O VAL 104 A O VAL 104 A N TYR 96 A N TYR 96 A O ALA 99 A O ALA 99 1 A A OE2 HH12 GLU ARG 35 51 1.59 2 A A HZ2 OE1 LYS GLU 24 41 1.60 3 A A HZ3 OE2 LYS GLU 24 43 1.55 4 A A OE2 HH12 GLU ARG 43 51 1.58 7 A A HZ1 OE2 LYS GLU 24 41 1.60 8 A A O HG1 ASP THR 46 47 1.59 9 A A HZ1 OE1 LYS GLU 24 41 1.59 9 A A O HG ALA CYS 88 103 1.60 11 A A HZ3 OD2 LYS ASP 24 39 1.57 12 A A HZ2 OD2 LYS ASP 24 39 1.57 18 A A HZ1 OD1 LYS ASP 24 39 1.58 19 A A O HG1 ARG THR 72 73 1.56 1 A SER 5 61.43 -161.51 1 A GLU 8 -121.01 -168.19 1 A GLU 20 -68.77 4.73 1 A SER 42 49.59 94.37 1 A LEU 44 58.94 85.25 1 A THR 47 75.20 -48.25 1 A GLU 48 59.27 11.14 1 A THR 49 49.16 24.43 1 A THR 52 71.98 136.29 1 A TYR 55 72.78 -40.95 1 A ALA 80 69.67 -23.78 1 A ARG 90 49.35 -113.08 1 A HIS 120 -133.06 -37.76 1 A HIS 123 74.54 -37.35 2 A GLU 8 -102.18 59.83 2 A THR 9 48.39 76.20 2 A ARG 19 -74.21 -83.30 2 A GLU 20 179.85 -52.56 2 A ALA 21 -68.17 0.37 2 A THR 23 -45.11 -71.59 2 A GLU 38 -90.06 -138.85 2 A ASP 39 71.19 -75.26 2 A LEU 40 38.34 88.63 2 A GLU 41 -114.22 -74.73 2 A GLU 43 42.31 82.47 2 A LEU 44 56.71 -172.80 2 A ASP 46 70.99 -31.80 2 A MET 50 64.39 74.70 2 A GLN 58 69.56 122.40 2 A ASN 62 54.24 84.82 2 A ARG 65 -178.63 -173.44 2 A SER 67 -77.08 20.51 2 A ARG 72 -91.48 -76.35 2 A ALA 80 69.71 -41.37 2 A TYR 106 -59.26 106.82 2 A HIS 121 71.73 -46.80 2 A HIS 123 -124.85 -167.02 3 A LEU 3 62.91 -176.10 3 A GLU 8 51.74 86.05 3 A GLU 20 -69.32 85.46 3 A ALA 21 -171.47 -37.18 3 A THR 23 -45.04 -72.88 3 A GLU 35 66.45 112.66 3 A ILE 36 -145.65 -47.86 3 A GLU 41 -176.54 123.14 3 A SER 42 57.73 83.80 3 A GLU 43 -135.37 -66.28 3 A THR 47 59.69 15.81 3 A THR 52 59.85 81.25 3 A ARG 72 -111.64 -73.17 3 A ALA 80 71.80 -34.51 3 A ARG 90 -47.65 89.66 3 A GLU 91 -158.84 88.72 3 A HIS 121 72.61 137.41 3 A HIS 123 63.68 -82.30 4 A ARG 19 -90.00 -83.14 4 A GLU 20 -178.32 -42.25 4 A LEU 37 69.14 -178.93 4 A LEU 40 -100.88 -104.50 4 A GLU 41 66.26 147.56 4 A GLU 43 -77.76 -82.64 4 A THR 52 57.35 125.18 4 A GLN 58 54.34 79.34 4 A GLN 59 40.57 79.69 4 A ARG 63 -132.91 -157.08 4 A ARG 72 -174.57 -43.32 4 A ALA 80 71.28 -45.71 4 A HIS 92 -168.08 91.60 4 A CYS 97 70.37 -52.79 4 A HIS 120 -85.48 45.32 5 A ALA 21 178.79 -33.38 5 A ALA 31 -59.99 -6.79 5 A PHE 33 -138.24 -69.37 5 A LEU 37 64.59 -167.48 5 A GLU 41 62.22 -81.54 5 A LEU 44 45.97 73.51 5 A GLN 59 -169.89 99.11 5 A ARG 72 -161.62 -54.40 5 A GLU 91 -162.06 85.01 5 A HIS 92 -150.25 24.31 5 A GLU 117 -162.93 -68.95 5 A HIS 122 65.39 -62.42 5 A HIS 123 -147.67 -34.49 6 A SER 7 57.13 18.29 6 A GLU 8 58.31 19.13 6 A GLN 25 -93.02 -67.44 6 A ALA 31 -42.11 -13.01 6 A LEU 40 -129.81 -81.18 6 A GLU 41 64.88 -63.63 6 A GLU 43 -124.20 -144.47 6 A PHE 57 44.50 -178.26 6 A ALA 80 80.90 -1.31 6 A ARG 90 47.44 -137.45 6 A HIS 120 -82.40 32.56 6 A HIS 121 62.31 -101.54 7 A SER 2 -157.58 -21.01 7 A SER 7 -106.60 69.80 7 A THR 9 -92.56 -69.21 7 A ALA 21 -171.05 -30.74 7 A ILE 36 -120.67 -83.51 7 A LEU 37 -67.17 -75.21 7 A GLU 38 -175.89 39.83 7 A THR 52 53.51 176.43 7 A PRO 53 -69.74 20.18 7 A GLN 58 -46.66 103.50 7 A ALA 60 65.01 159.18 7 A SER 67 174.63 -42.66 7 A ARG 72 -122.65 -143.10 7 A THR 73 -77.79 36.02 7 A ALA 80 70.67 -44.72 7 A ARG 90 -62.27 36.17 7 A HIS 92 -137.07 -70.51 7 A PRO 105 -75.30 45.92 7 A TYR 106 58.70 111.72 7 A GLU 117 46.82 25.13 8 A THR 9 71.74 -58.99 8 A ALA 21 -177.07 -32.73 8 A LEU 37 68.76 -176.10 8 A LEU 40 -133.10 -77.73 8 A GLU 41 68.72 -66.34 8 A SER 42 -154.16 89.51 8 A GLU 43 -79.37 -73.88 8 A THR 47 57.81 18.60 8 A THR 52 57.16 175.63 8 A PRO 53 -76.35 26.07 8 A PHE 56 -65.10 -72.28 8 A PHE 57 -170.91 129.89 8 A ARG 65 51.74 -94.57 8 A GLU 91 -126.23 -119.97 8 A HIS 92 54.66 -96.47 8 A HIS 120 49.84 -131.58 9 A THR 9 72.78 -39.10 9 A TYR 29 -92.41 -72.36 9 A ILE 36 -123.44 -80.37 9 A ASP 39 70.38 83.36 9 A LEU 40 -104.91 -60.15 9 A GLU 41 54.62 -128.38 9 A LEU 44 -131.28 -51.19 9 A ASP 46 76.54 -41.05 9 A THR 52 46.32 88.73 9 A GLN 59 -88.25 -138.41 9 A ALA 60 71.36 164.35 9 A ARG 64 59.00 176.70 9 A ILE 66 53.53 122.58 9 A ALA 80 67.44 -55.47 9 A ARG 90 -31.37 100.03 9 A GLU 91 -165.24 78.30 9 A GLU 117 62.76 69.05 9 A HIS 122 177.24 110.83 10 A SER 7 71.71 85.93 10 A THR 9 60.26 84.60 10 A THR 23 -44.26 -71.45 10 A GLN 25 -60.77 -71.36 10 A ALA 31 -38.19 -29.32 10 A ILE 36 -134.40 -63.47 10 A ASP 39 71.78 171.79 10 A LEU 40 -115.33 -79.52 10 A GLU 41 -150.64 -40.42 10 A GLU 43 -132.35 -57.92 10 A TYR 55 77.09 167.89 10 A ALA 60 65.57 161.18 10 A SER 67 155.96 -35.47 10 A ARG 72 -169.80 -56.18 10 A TYR 106 -61.78 98.70 11 A ALA 21 -151.50 -36.09 11 A ILE 22 -82.86 30.20 11 A THR 23 -46.71 -76.68 11 A TYR 29 -94.78 -63.35 11 A LEU 40 -172.07 109.75 11 A GLU 41 -128.77 -73.40 11 A GLU 43 -126.93 -66.58 11 A ARG 51 -142.14 -83.91 11 A PHE 56 -167.89 -70.56 11 A PHE 57 42.56 27.71 11 A GLN 58 70.39 -44.76 11 A ILE 66 -100.08 -157.93 11 A THR 73 57.90 10.03 11 A ALA 80 71.44 -63.82 11 A HIS 123 -171.14 119.64 12 A GLU 6 -102.60 72.02 12 A THR 9 71.85 -58.51 12 A ARG 19 -85.07 -86.59 12 A GLU 20 -165.16 -65.91 12 A ILE 36 -137.35 -76.09 12 A LEU 40 -126.58 -71.24 12 A GLU 41 65.01 -70.39 12 A GLU 43 -91.07 -74.07 12 A LEU 44 -126.93 -51.88 12 A THR 47 -79.59 -91.31 12 A GLU 48 65.48 -37.08 12 A THR 52 58.94 159.93 12 A ALA 60 72.64 142.90 12 A ASN 62 -107.63 -80.59 12 A ALA 80 69.88 -61.72 12 A CYS 97 70.42 -15.39 12 A LYS 107 63.24 124.56 13 A SER 2 66.45 93.25 13 A SER 5 70.51 162.67 13 A SER 7 -167.72 100.29 13 A GLU 20 -67.41 77.39 13 A ALA 21 -175.07 -30.39 13 A ILE 22 -87.12 34.64 13 A LEU 37 75.53 167.46 13 A ASP 39 -65.09 -79.90 13 A LEU 40 42.62 87.99 13 A SER 42 -158.06 83.61 13 A GLU 43 -90.45 -80.11 13 A GLU 48 -80.38 37.39 13 A MET 50 -78.55 37.89 13 A GLN 58 72.15 116.46 13 A ARG 64 -69.25 87.07 13 A GLU 91 -146.21 13.01 13 A HIS 92 -110.97 -70.35 13 A TYR 106 -63.72 95.83 13 A GLU 117 70.05 96.53 13 A HIS 123 65.38 -81.00 14 A SER 7 -90.00 -136.05 14 A ALA 21 -176.62 -29.88 14 A ILE 22 -97.53 31.24 14 A ILE 36 -107.09 -77.55 14 A ASP 39 52.36 76.69 14 A GLU 41 43.63 -94.27 14 A GLU 43 -63.81 -78.43 14 A LEU 44 -160.87 -54.58 14 A ASP 46 -91.37 -85.04 14 A THR 47 -90.38 37.70 14 A THR 52 65.51 122.95 14 A PRO 53 -76.99 47.23 14 A GLN 58 -56.44 98.98 14 A ARG 72 -128.09 -85.57 14 A ALA 80 70.36 -53.61 14 A ARG 90 -58.10 86.60 14 A HIS 92 -59.79 91.78 14 A CYS 97 73.62 -37.01 14 A TYR 106 -56.89 102.29 14 A GLU 117 51.28 81.35 14 A HIS 119 55.05 -64.22 14 A HIS 121 -93.86 -81.14 14 A HIS 123 70.95 -46.12 15 A THR 9 -94.17 30.77 15 A ALA 21 -168.23 -39.66 15 A PHE 33 -95.75 -67.65 15 A LEU 40 -173.14 101.86 15 A GLU 43 -90.99 -78.85 15 A THR 47 -164.32 33.20 15 A THR 52 57.97 158.77 15 A PRO 53 -69.91 -156.25 15 A GLN 58 66.91 120.78 15 A GLN 59 -69.60 88.75 15 A ALA 80 69.95 -36.23 15 A ARG 90 -49.04 108.94 15 A TYR 106 -60.03 97.86 16 A SER 5 69.59 163.14 16 A SER 7 -115.78 -113.35 16 A ALA 21 -158.49 9.19 16 A GLU 41 -97.50 -81.05 16 A SER 42 -103.88 -61.90 16 A GLU 43 65.43 100.29 16 A LEU 44 51.22 -137.63 16 A THR 52 56.60 174.28 16 A GLN 58 59.75 172.97 16 A GLN 59 -132.24 -75.09 16 A ALA 60 43.70 84.27 16 A ALA 80 68.31 -59.37 16 A ARG 90 -53.43 102.08 16 A GLU 117 64.83 80.07 16 A HIS 122 -153.01 -58.61 17 A LEU 37 50.77 -107.57 17 A GLU 38 -169.31 -54.16 17 A LEU 40 -70.76 -74.99 17 A GLU 41 65.05 -74.78 17 A GLU 43 -105.55 -93.61 17 A ASP 46 75.46 169.12 17 A GLN 58 74.96 97.89 17 A ARG 72 -86.94 -82.98 17 A ALA 80 66.53 -1.19 17 A THR 94 54.65 -165.04 17 A CYS 97 71.46 -36.40 18 A LEU 3 55.18 -89.11 18 A SER 5 64.64 -50.56 18 A SER 7 -114.95 -149.26 18 A THR 9 71.66 -68.73 18 A ILE 22 -88.35 30.78 18 A THR 23 -43.90 -73.50 18 A LEU 37 71.82 -107.35 18 A GLU 38 -164.13 -67.77 18 A ASP 39 62.74 -169.82 18 A LEU 40 -160.80 3.77 18 A THR 47 -83.07 -84.28 18 A GLU 48 66.39 -38.31 18 A ARG 51 -129.40 -140.75 18 A PRO 53 -74.92 38.33 18 A ALA 60 63.76 149.86 18 A ARG 63 -119.77 -153.31 18 A ARG 64 -55.88 101.02 18 A SER 67 170.94 -42.57 18 A ARG 72 51.32 -90.20 18 A ALA 80 68.12 -48.81 18 A ARG 90 -37.88 130.78 18 A GLU 91 -136.40 -153.88 18 A GLU 117 61.77 64.60 19 A LEU 3 50.20 76.54 19 A ILE 22 -99.42 30.98 19 A PHE 33 -158.89 53.32 19 A LEU 37 64.67 -169.27 19 A GLU 41 54.97 -92.48 19 A GLU 43 -100.20 -105.81 19 A LEU 44 -118.66 -74.13 19 A THR 52 168.94 158.62 19 A GLN 58 -63.68 15.05 19 A ILE 66 -50.64 -72.58 19 A SER 67 46.01 21.78 19 A THR 73 72.19 -11.20 19 A ALA 80 70.22 -5.28 19 A ARG 90 56.75 -120.65 19 A HIS 119 70.49 143.20 20 A GLU 20 -78.08 46.35 20 A THR 23 -50.94 -73.67 20 A GLN 25 -66.61 -71.59 20 A LEU 37 72.98 -177.71 20 A GLU 41 85.24 -53.00 20 A LEU 44 -115.06 -165.98 20 A THR 52 61.69 120.21 20 A TYR 55 73.38 87.29 20 A PHE 56 61.73 119.59 20 A GLN 58 62.66 99.00 20 A ALA 60 58.08 104.34 20 A ASN 62 80.64 -15.49 20 A ARG 63 -104.54 -158.74 20 A ARG 72 -105.57 -72.25 20 A ALA 80 73.18 -53.51 lowest energy, model1 Solution structure of the RRM domain of the hypothetical protein CAGL0M09691g from Candida glabrata 1 N N A ILE 22 A ILE 22 HELX_P A ALA 31 A ALA 31 1 1 10 A THR 47 A THR 47 HELX_P A ARG 51 A ARG 51 5 2 5 A ASN 81 A ASN 81 HELX_P A ARG 90 A ARG 90 1 3 10 A LYS 107 A LYS 107 HELX_P A GLY 118 A GLY 118 1 4 12 UNKNOWN FUNCTION STRUCTURAL GENOMICS, UNKNOWN FUNCTION, THIOREDOXIN-LIKE, New York Structural Genomics Research Consortium, NYSGRC, Nucleocytoplasmic Transport: a Target for Cellular Control, PSI-Biology, NPCXstals Q6FJ27_CANGA UNP 1 171 Q6FJ27 GSESETGNAVVVFGYREAITKQILAYFAQFGEILEDLESELGDTETMRTPGYFFQQAPNRRRISREHGRTWTKLTYANHS SYLRALREHGTIYCGAAIGCVPYKHELISELSR 171 283 2M4M 4 116 Q6FJ27 A 1 4 116 1 expression tag MET 1 2M4M A Q6FJ27 UNP 1 1 expression tag SER 2 2M4M A Q6FJ27 UNP 2 1 expression tag LEU 3 2M4M A Q6FJ27 UNP 3 1 expression tag GLU 117 2M4M A Q6FJ27 UNP 117 1 expression tag GLY 118 2M4M A Q6FJ27 UNP 118 1 expression tag HIS 119 2M4M A Q6FJ27 UNP 119 1 expression tag HIS 120 2M4M A Q6FJ27 UNP 120 1 expression tag HIS 121 2M4M A Q6FJ27 UNP 121 1 expression tag HIS 122 2M4M A Q6FJ27 UNP 122 1 expression tag HIS 123 2M4M A Q6FJ27 UNP 123 1 expression tag HIS 124 2M4M A Q6FJ27 UNP 124 3 2 anti-parallel anti-parallel anti-parallel A TRP 74 A TRP 74 A THR 78 A THR 78 A ALA 12 A ALA 12 A PHE 16 A PHE 16 A GLY 102 A GLY 102 A PRO 105 A PRO 105 A ILE 95 A ILE 95 A TYR 96 A TYR 96 A ALA 99 A ALA 99 A ALA 100 A ALA 100